This is the authors' abstract. We don't add key points for this paper.
The aim of this study was to investigate the cytotoxic and mechanistic effects of harmine (HAR), harmaline (HAL), and the alkaloid extract of Peganum harmala L., on oxaliplatin-resistant HCT116 (HCT116/OXA) cells and human dermal fibroblast (HDF) cells. These compounds exhibited significant cytotoxicity in both cell types. At 48 h, the IC50 values of P. harmala’s alkaloid extract, HAR, and HAL were 10, 3.4 and 29.9 μg/mL in HCT116/OXA cells, and 15.1, 8 and 41.7 μg/mL in HDF cells. The results indicated that the toxic effects of these compounds were greater on the resistant cancer cells compared to the normal cells. Our research demonstrated that the alkaloid extract of Peganum harmala L. triggers apoptosis and G1 phase cell cycle arrest in HCT116/OXA cells. Additionally, HAR, HAL, and P. harmala’s alkaloid extract markedly decreased GSK3β expression and increased BAX expression. These results may offer therapeutic potential in oxaliplatin-resistant phenotypes.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Salimizadeh et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: